Efficacy and safety of subcutaneous golimumab in methotrexate-naïve patients with rheumatoid arthritis: 5-year results of the GO-BEFORE trial.
2016
Evaluate the safety and efficacy of golimumab through 5 years in adults with active RA who had not previously received methotrexate (MTX).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI